'It's time to go big,' says OneWorld Health's Richard Chin

Daunting science, technology and business questions aside, as OneWorld Health and its partners move closer to launching a semisynthetic version of a key anti-malaria drug ingredient, CEO Richard Chin is thinking a lot about history.